Arecor Therapeutics PLC (LON:AREC)
66.00p
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Insulin delivery innovation is promising but cash runs out in 2027; binary clinical risk limits upside.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Arecor Therapeutics PLC
Arecor Therapeutics plc, a clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom. The company through its proprietary reformulation technology platform, Arestat, developing a portfolio of proprietary…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £24.9M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Arecor Therapeutics PLC and 1,600+ UK and US stocks.
Start free